GRI Bio, Inc.

GRI Bio, Inc. - PE Ratioverified

GRI

Price:

$1.88

Market Cap:

$168.88K

GRI Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutic agents within the United States. Its primary focus lies in addressing inflammatory, fibrotic, and autoimmune disorders. The company's leading drug candidate is GRI-0621, an oral inhibitor targeting type 1 Natural Killer T cells, which is currently undergoing Phase IIa clinical trials. This investigational treatment is being evaluated for severe fibrotic lung conditions, including idiopathic pulmonary fibrosis. Beyond its flagship program, GRI Bio's pipeline also features GRI-0803, a novel oral agonist designed to activate type 2 Natural Killer T cells, cur...[Read more]

Industry

Biotechnology

IPO Date

2023-04-24

Stock Exchange

NASDAQ

Ticker

GRI

The PE Ratio as of June 2026 (TTM) for GRI Bio, Inc. (GRI) is 0.05

According to GRI Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.05. This represents a change of -118.44% compared to the average of -0.27 of the last 4 quarters.

GRI Bio, Inc. (GRI) Historical PE Ratio (quarterly & annually)

How has GRI PE Ratio performed in the past?

The mean historical PE Ratio of GRI Bio, Inc. over the last ten years is -611.02. The current 0.05 PE Ratio has changed -100.82% with respect to the historical average. Over the past ten years (40 quarters), GRI's PE Ratio was at its highest in in the March 2023 quarter at 5.33. The PE Ratio was at its lowest in in the December 2021 quarter at -2928.79.

Quarterly (TTM)
Annual

Average

-611.02

Median

-10.00

Minimum

-2748.66

Maximum

-0.06

GRI Bio, Inc. (GRI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of GRI Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 13.98%

Maximum Annual PE Ratio = -0.06

Minimum Annual Increase = -99.71%

Minimum Annual PE Ratio = -2748.66

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.06-77.75%
2024-0.26114.81%
2023-0.12-98.52%
2022-8.00-99.71%
2021-2748.6630.63%
2020-2104.1313.98%
2019-14.9424.48%

GRI Bio, Inc. (GRI) Average PE Ratio

How has GRI PE Ratio performed in the past?

The current PE Ratio of GRI Bio, Inc. (GRI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.14

5-year avg

-551.42

10-year avg

-611.02

GRI Bio, Inc. (GRI) PE Ratio vs. Peers

How is GRI’s PE Ratio compared to its peers?

GRI Bio, Inc.’s PE Ratio is greater than CNS Pharmaceuticals, Inc. (-0.16), greater than Jaguar Health, Inc. (-0.00), greater than Silo Pharma, Inc. (-0.82), greater than Biodexa Pharmaceuticals Plc (-0.00), greater than Abpro Corporation (-0.04), greater than InMed Pharmaceuticals Inc. (-0.00), greater than Can-Fite BioPharma Ltd. (-686.14), greater than 60 Degrees Pharmaceuticals, Inc. (-0.16), greater than Genprex, Inc. (-0.04), greater than Calidi Biotherapeutics, Inc. (-0.03),

Build a custom stock screener for GRI Bio, Inc. (GRI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GRI Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GRI Bio, Inc. (GRI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GRI Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is GRI Bio, Inc.'s PE Ratio?

How is the PE Ratio calculated for GRI Bio, Inc. (GRI)?

What is the highest PE Ratio for GRI Bio, Inc. (GRI)?

What is the 3-year average PE Ratio for GRI Bio, Inc. (GRI)?

What is the 5-year average PE Ratio for GRI Bio, Inc. (GRI)?

How does the current PE Ratio for GRI Bio, Inc. (GRI) compare to its historical average?